BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22590589)

  • 21. Application of hybrid biophysical-biochemical methods to unravel the molecular basis for auto-inhibition and activation of protein tyrosine phosphatase TCPTP/PTPN2.
    Singh JP; Chen YY; Huang YT; Hsu SD; Meng TC
    Methods Enzymol; 2023; 682():351-374. PubMed ID: 36948707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTPN2 Regulates Metabolic Flux to Affect β-Cell Susceptibility to Inflammatory Stress.
    Kim YK; Kim YR; Wells KL; Sarbaugh D; Guney M; Tsai CF; Zee T; Karsenty G; Nakayasu ES; Sussel L
    Diabetes; 2024 Mar; 73(3):434-447. PubMed ID: 38015772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer.
    Spalinger MR; Manzini R; Hering L; Riggs JB; Gottier C; Lang S; Atrott K; Fettelschoss A; Olomski F; Kündig TM; Fried M; McCole DF; Rogler G; Scharl M
    Cell Rep; 2018 Feb; 22(7):1835-1848. PubMed ID: 29444435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
    Veenstra C; Karlsson E; Mirwani SM; Nordenskjöld B; Fornander T; Pérez-Tenorio G; Stål O
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1845-1856. PubMed ID: 31025094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal Structure of TCPTP Unravels an Allosteric Regulatory Role of Helix α7 in Phosphatase Activity.
    Singh JP; Lin MJ; Hsu SF; Peti W; Lee CC; Meng TC
    Biochemistry; 2021 Dec; 60(51):3856-3867. PubMed ID: 34910875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.
    Duval R; Bui LC; Mathieu C; Nian Q; Berthelet J; Xu X; Haddad I; Vinh J; Dupret JM; Busi F; Guidez F; Chomienne C; Rodrigues-Lima F
    J Biol Chem; 2019 Aug; 294(33):12483-12494. PubMed ID: 31248982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell type-specific role of protein tyrosine phosphatase non-receptor type 2 in regulating ER stress signalling.
    Kasper SH; Spalinger MR; Raselli T; Scharl M
    Digestion; 2015; 91(3):248-56. PubMed ID: 25823847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis.
    Morón B; Spalinger M; Kasper S; Atrott K; Frey-Wagner I; Fried M; McCole DF; Rogler G; Scharl M
    PLoS One; 2013; 8(9):e73703. PubMed ID: 24040033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frederiksen B; Liu E; Romanos J; Steck AK; Yin X; Kroehl M; Fingerlin TE; Erlich H; Eisenbarth GS; Rewers M; Norris JM
    J Steroid Biochem Mol Biol; 2013 Jan; 133():51-7. PubMed ID: 22960018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPN2 is associated with Crohn's disease and its expression is regulated by NKX2-3.
    Yu W; Hegarty JP; Berg A; Kelly AA; Wang Y; Poritz LS; Franke A; Schreiber S; Koltun WA; Lin Z
    Dis Markers; 2012; 32(2):83-91. PubMed ID: 22377701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
    Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
    J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance.
    Hering L; Katkeviciute E; Schwarzfischer M; Busenhart P; Gottier C; Mrdjen D; Komuczki J; Wawrzyniak M; Lang S; Atrott K; Becher B; Rogler G; Scharl M; Spalinger MR
    Front Immunol; 2020; 11():1856. PubMed ID: 32973765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of PTPN2 and its use as a biomarker.
    Bussières-Marmen S; Hutchins AP; Schirbel A; Rebert N; Tiganis T; Fiocchi C; Miranda-Saavedra D; Tremblay ML
    Methods; 2014 Jan; 65(2):239-46. PubMed ID: 23994241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune susceptibility gene
    Spalinger MR; Shawki A; Chatterjee P; Canale V; Santos A; Sayoc-Becerra A; Scharl M; Tremblay ML; Borneman J; McCole DF
    Gut; 2022 Jan; 71(1):89-99. PubMed ID: 33563644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
    Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
    Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
    Katkeviciute E; Hering L; Montalban-Arques A; Busenhart P; Schwarzfischer M; Manzini R; Conde J; Atrott K; Lang S; Rogler G; Naschberger E; Schellerer VS; Stürzl M; Rickenbacher A; Turina M; Weber A; Leibl S; Leventhal GE; Levesque M; Boyman O; Scharl M; Spalinger MR
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33001862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis.
    Hsieh WC; Svensson MN; Zoccheddu M; Tremblay ML; Sakaguchi S; Stanford SM; Bottini N
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice.
    You-Ten KE; Muise ES; Itié A; Michaliszyn E; Wagner J; Jothy S; Lapp WS; Tremblay ML
    J Exp Med; 1997 Aug; 186(5):683-93. PubMed ID: 9271584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.